Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response

Jessica Whritenour, Mira Ko, Qing Zong, Jianying Wang, Karrie Tartaro, Patricia Schneider, Ellen Olson, Maria Van Volkenburg, Jose Serrano, Paul Hayashi, Robert Fontana, Naga Chalasani, Herbert L. Bonkovsky

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Drug-induced liver injury (DILI) is a growing problem. Diagnostic methods to differentiate DILI caused by an adaptive immune response from liver injury of other causes or to identify the responsible drug in patients receiving multiple drugs, herbals and/or dietary supplements (polypharmacy) have not yet been established. The lymphocyte transformation test (LTT) has been proposed as a diagnostic method to determine if a subject with an apparent hypersensitivity reaction has become sensitized to a specific drug. In this test, peripheral blood mononuclear cells (PBMC) collected from a subject are incubated with drug(s) suspected of causing the reaction. Cell proliferation, measured by the incorporation of [3H]-thymidine into new DNA, is considered evidence of a drug-specific immune response. The objectives of the current studies were to: (1) develop and optimize a modified version of the LTT (mLTT) and (2) investigate the feasibility of using the mLTT for diagnosing DILI associated with an adaptive immune response and identifying the responsible drug. PBMC collected from donors with a history of drug hypersensitivity reactions to specific drugs (manifested as skin rash) were used as positive controls for assay optimization. Following optimization, samples collected from 24 subjects enrolled in the U.S. Drug-Induced Liver Injury Network (DILIN) were tested in the mLTT. Using cytokine and granzyme B production as the primary endpoints to demonstrate lymphocyte sensitization to a specific drug, most samples from the DILIN subjects failed to respond. However, robust positive mLTT responses were observed for two of four samples from three DILIN subjects with hepatitis due to isoniazid (INH). We conclude that the mLTT, as performed here on frozen and thawed PBMC, is not a reliable test for diagnosing DILI caused by all drugs, but that it may be useful for confirming the role of the adaptive immune response in DILI ascribed to INH.

Original languageEnglish (US)
Pages (from-to)31-38
Number of pages8
JournalJournal of Immunotoxicology
Volume14
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Chemical and Drug Induced Liver Injury
Lymphocytes
Adaptive Immunity
Lymphocyte Activation
Liver
Pharmaceutical Preparations
Blood Cells
Drug Hypersensitivity
Polypharmacy
Granzymes
Blood
Isoniazid
Dietary Supplements
Exanthema
Thymidine
Hepatitis
Hypersensitivity
Dietary supplements
Cell Proliferation
Tissue Donors

Keywords

  • Allergic reactions
  • drug-induced liver injury
  • drugs
  • hepatitis
  • immuno-allergic
  • lymphocyte transformation test
  • lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Toxicology

Cite this

Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response. / Whritenour, Jessica; Ko, Mira; Zong, Qing; Wang, Jianying; Tartaro, Karrie; Schneider, Patricia; Olson, Ellen; Van Volkenburg, Maria; Serrano, Jose; Hayashi, Paul; Fontana, Robert; Chalasani, Naga; Bonkovsky, Herbert L.

In: Journal of Immunotoxicology, Vol. 14, No. 1, 01.12.2017, p. 31-38.

Research output: Contribution to journalArticle

Whritenour, J, Ko, M, Zong, Q, Wang, J, Tartaro, K, Schneider, P, Olson, E, Van Volkenburg, M, Serrano, J, Hayashi, P, Fontana, R, Chalasani, N & Bonkovsky, HL 2017, 'Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response', Journal of Immunotoxicology, vol. 14, no. 1, pp. 31-38. https://doi.org/10.1080/1547691X.2016.1254305
Whritenour, Jessica ; Ko, Mira ; Zong, Qing ; Wang, Jianying ; Tartaro, Karrie ; Schneider, Patricia ; Olson, Ellen ; Van Volkenburg, Maria ; Serrano, Jose ; Hayashi, Paul ; Fontana, Robert ; Chalasani, Naga ; Bonkovsky, Herbert L. / Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response. In: Journal of Immunotoxicology. 2017 ; Vol. 14, No. 1. pp. 31-38.
@article{658d6250318640ae9e73506fea419384,
title = "Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response",
abstract = "Drug-induced liver injury (DILI) is a growing problem. Diagnostic methods to differentiate DILI caused by an adaptive immune response from liver injury of other causes or to identify the responsible drug in patients receiving multiple drugs, herbals and/or dietary supplements (polypharmacy) have not yet been established. The lymphocyte transformation test (LTT) has been proposed as a diagnostic method to determine if a subject with an apparent hypersensitivity reaction has become sensitized to a specific drug. In this test, peripheral blood mononuclear cells (PBMC) collected from a subject are incubated with drug(s) suspected of causing the reaction. Cell proliferation, measured by the incorporation of [3H]-thymidine into new DNA, is considered evidence of a drug-specific immune response. The objectives of the current studies were to: (1) develop and optimize a modified version of the LTT (mLTT) and (2) investigate the feasibility of using the mLTT for diagnosing DILI associated with an adaptive immune response and identifying the responsible drug. PBMC collected from donors with a history of drug hypersensitivity reactions to specific drugs (manifested as skin rash) were used as positive controls for assay optimization. Following optimization, samples collected from 24 subjects enrolled in the U.S. Drug-Induced Liver Injury Network (DILIN) were tested in the mLTT. Using cytokine and granzyme B production as the primary endpoints to demonstrate lymphocyte sensitization to a specific drug, most samples from the DILIN subjects failed to respond. However, robust positive mLTT responses were observed for two of four samples from three DILIN subjects with hepatitis due to isoniazid (INH). We conclude that the mLTT, as performed here on frozen and thawed PBMC, is not a reliable test for diagnosing DILI caused by all drugs, but that it may be useful for confirming the role of the adaptive immune response in DILI ascribed to INH.",
keywords = "Allergic reactions, drug-induced liver injury, drugs, hepatitis, immuno-allergic, lymphocyte transformation test, lymphocytes",
author = "Jessica Whritenour and Mira Ko and Qing Zong and Jianying Wang and Karrie Tartaro and Patricia Schneider and Ellen Olson and {Van Volkenburg}, Maria and Jose Serrano and Paul Hayashi and Robert Fontana and Naga Chalasani and Bonkovsky, {Herbert L.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1080/1547691X.2016.1254305",
language = "English (US)",
volume = "14",
pages = "31--38",
journal = "Journal of Immunotoxicology",
issn = "1547-691X",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response

AU - Whritenour, Jessica

AU - Ko, Mira

AU - Zong, Qing

AU - Wang, Jianying

AU - Tartaro, Karrie

AU - Schneider, Patricia

AU - Olson, Ellen

AU - Van Volkenburg, Maria

AU - Serrano, Jose

AU - Hayashi, Paul

AU - Fontana, Robert

AU - Chalasani, Naga

AU - Bonkovsky, Herbert L.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Drug-induced liver injury (DILI) is a growing problem. Diagnostic methods to differentiate DILI caused by an adaptive immune response from liver injury of other causes or to identify the responsible drug in patients receiving multiple drugs, herbals and/or dietary supplements (polypharmacy) have not yet been established. The lymphocyte transformation test (LTT) has been proposed as a diagnostic method to determine if a subject with an apparent hypersensitivity reaction has become sensitized to a specific drug. In this test, peripheral blood mononuclear cells (PBMC) collected from a subject are incubated with drug(s) suspected of causing the reaction. Cell proliferation, measured by the incorporation of [3H]-thymidine into new DNA, is considered evidence of a drug-specific immune response. The objectives of the current studies were to: (1) develop and optimize a modified version of the LTT (mLTT) and (2) investigate the feasibility of using the mLTT for diagnosing DILI associated with an adaptive immune response and identifying the responsible drug. PBMC collected from donors with a history of drug hypersensitivity reactions to specific drugs (manifested as skin rash) were used as positive controls for assay optimization. Following optimization, samples collected from 24 subjects enrolled in the U.S. Drug-Induced Liver Injury Network (DILIN) were tested in the mLTT. Using cytokine and granzyme B production as the primary endpoints to demonstrate lymphocyte sensitization to a specific drug, most samples from the DILIN subjects failed to respond. However, robust positive mLTT responses were observed for two of four samples from three DILIN subjects with hepatitis due to isoniazid (INH). We conclude that the mLTT, as performed here on frozen and thawed PBMC, is not a reliable test for diagnosing DILI caused by all drugs, but that it may be useful for confirming the role of the adaptive immune response in DILI ascribed to INH.

AB - Drug-induced liver injury (DILI) is a growing problem. Diagnostic methods to differentiate DILI caused by an adaptive immune response from liver injury of other causes or to identify the responsible drug in patients receiving multiple drugs, herbals and/or dietary supplements (polypharmacy) have not yet been established. The lymphocyte transformation test (LTT) has been proposed as a diagnostic method to determine if a subject with an apparent hypersensitivity reaction has become sensitized to a specific drug. In this test, peripheral blood mononuclear cells (PBMC) collected from a subject are incubated with drug(s) suspected of causing the reaction. Cell proliferation, measured by the incorporation of [3H]-thymidine into new DNA, is considered evidence of a drug-specific immune response. The objectives of the current studies were to: (1) develop and optimize a modified version of the LTT (mLTT) and (2) investigate the feasibility of using the mLTT for diagnosing DILI associated with an adaptive immune response and identifying the responsible drug. PBMC collected from donors with a history of drug hypersensitivity reactions to specific drugs (manifested as skin rash) were used as positive controls for assay optimization. Following optimization, samples collected from 24 subjects enrolled in the U.S. Drug-Induced Liver Injury Network (DILIN) were tested in the mLTT. Using cytokine and granzyme B production as the primary endpoints to demonstrate lymphocyte sensitization to a specific drug, most samples from the DILIN subjects failed to respond. However, robust positive mLTT responses were observed for two of four samples from three DILIN subjects with hepatitis due to isoniazid (INH). We conclude that the mLTT, as performed here on frozen and thawed PBMC, is not a reliable test for diagnosing DILI caused by all drugs, but that it may be useful for confirming the role of the adaptive immune response in DILI ascribed to INH.

KW - Allergic reactions

KW - drug-induced liver injury

KW - drugs

KW - hepatitis

KW - immuno-allergic

KW - lymphocyte transformation test

KW - lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=85024374443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024374443&partnerID=8YFLogxK

U2 - 10.1080/1547691X.2016.1254305

DO - 10.1080/1547691X.2016.1254305

M3 - Article

C2 - 28121193

AN - SCOPUS:85024374443

VL - 14

SP - 31

EP - 38

JO - Journal of Immunotoxicology

JF - Journal of Immunotoxicology

SN - 1547-691X

IS - 1

ER -